Alembic Pharma drops 2% on USFDA 4 observations for Gujarat facility

The US drug regulator had inspected Alembic Pharma#39;s oncology formulations (injectable and oral solid) unit at Panelav in Gujarat from February 28 to March 8

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *